Axial3D raises $18.2 million to advance patient-specific surgery
With its $10 million investment, 57 Stars will become the company’s largest shareholder
Axial3D, an AI-powered 3D medical imaging algorithm, automated planning, and patient-specific 3D solutions company, has completed a new $18.2 million investment round. This latest funding includes continued support from Axial3D’s first-round investors Techstart, Innovation Ulster Limited, and US and NI business Angels as well as additional investment from Clarendon. It also welcomes three new strategic investors – 57 Stars, Whiterock, and Innovate UK. In particular, with its USD 10 million investment, 57 Stars – an American independent global alternative asset manager – will become the company’s largest shareholder.
“We are delighted to have completed this investment round, which will enable us to accelerate our mission of making patient-specific surgery routine globally,” said Roger Johnston, CEO of Axial3D. “Our market-fundamental patented technology platform empowers medical device companies, medical imaging companies, and hospitals to standardize the use of incredibly precise, patient-specific 3D data that transforms their offerings for patients. Our AI technology has the power to impact millions of patients globally across patient-specific applications in robotics, planning, and patient-specific device workflows.”
“Axial3D’s pioneering technology that creates patient-specific 3D imaging has already shown incredible potential in the Medtech space,” said Bernie McGuire, Managing Director and IC Member of 57 Stars. “We are excited to support their ongoing technology application expansion and look forward to seeing the impact their innovations will make in advancing personalized healthcare. This is the latest deal out of our long-standing Northern Ireland investment program, which has now committed over USD 50 million, and a prime example of our investment thesis of finding compelling opportunities at the intersection of healthcare and technology.”
“Axial3D’s technology addresses a critical need in healthcare – enabling scalability in personalized care. We’re proud to join this journey, supporting a company that is paving the way for more accessible and precise surgical solutions worldwide,” said Neil McCabe, Director of Whiterock.
